![Rajani Dinavahi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 759 780 $ al 31/08/2026
Rajani Dinavahi is currently Chief Medical Officer at Ardelyx, Inc. since 2026.
Formerly, Dr. Dinavahi was Chief Medical Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2024 to 2025.
Education includes undergraduate and doctorate degrees from the University of Miami.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARDELYX, INC. 0,08 % | 01/04/2026 | 201.000 ( 0,08 % ) | 759 780 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARDELYX, INC. | Director Técnico/Científico/I+D | 01/04/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/05/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
